Ultraconserved elements (UCEs) show the peculiar feature to retain extended perfect sequence identity among human, mouse, and rat genomes. Most of them are transcribed and represent a new family of long non-coding RNAs (lncRNAs), the transcribed UCEs (T-UCEs). Despite their involvement in human cancer, the physiological role of T-UCEs is still unknown. Here, we identify a lncRNA containing the uc.170+, named T-UCstem1, and provide in vitro and in vivo evidence that it plays essential roles in embryonic stem cells (ESCs) by modulating cytoplasmic miRNA levels and preserving transcriptional dynamics. Specifically, while T-UCstem1::miR-9 cytoplasmic interplay regulates ESC proliferation by reducing miR-9 levels, nuclear T-UCstem1 maintains ESC self-renewal and transcriptional identity by stabilizing polycomb repressive complex 2 on bivalent domains. Altogether, our findings provide unprecedented evidence that T-UCEs regulate physiological cellular functions and point to an essential role of T-UCstem1 in preserving ESC identity.
INTRODUCTION
Evolutionary conservation has become more and more a powerful tool to identify functionally important sequences in the genome (Dermitzakis et al., 2005) . In this context, the ultraconserved elements (UCEs) are 481 genomic segments longer than 200 base pairs (bp), which are fully conserved (100% identity with no insertions or deletions) between human, mouse, and rat genomes . This complete conservation led to the hypothesis that UCEs likely have biological functions fundamental to mammal cells (Katzman et al., 2007) . Despite extensive studies, our knowledge of UCEs is still limited. Indeed, increasing evidences indicate that UCEs play different functions in vertebrate genomes, acting as enhancer (Paparidis et al., 2007; Pennacchio et al., 2006) , splicing (Ni et al., 2007) , and epigenetic regulators (Bernstein et al., 2006; Lee et al., 2006) , or functioning as transcriptional coactivators (Feng et al., 2006) . In particular, many UCEs act as long-range enhancers during mouse development (Pennacchio et al., 2006) , and it has been proposed that their removal in vivo would lead to a significant phenotypic impact. Nevertheless, knockout studies performed so far indicate that UCEs are dispensable for mice viability (Ahituv et al., 2007; Nobrega et al., 2004) .
A large fraction of UCEs are transcribed (T-UCEs) in a tissue specific manner, and are deregulated in several human cancers (Calin et al., 2007; Fabbri et al., 2008; Fassan et al., 2014; Olivieri et al., 2016) . Indeed, it has been shown that T-UCEs may also act as long non-coding RNAs (lncRNAs) regulating other RNAs (Calin et al., 2007; Liz et al., 2014) . The main molecular mechanism of T-UCEs activity described so far is the ''decoy'' function. Indeed, T-UCEs sequester microRNAs (miRNAs) from the cytoplasm and eventually regulate cancer cell proliferation (Calin et al., 2007; Galasso et al., 2014; Olivieri et al., 2016) . All together these findings provided robust evidence supporting the functional role of T-UCEs in the human genome, and highlighted a link between these genomic elements and human disease. Nevertheless, currently very little is known on the physiological role of this specific class of lncRNAs, as for instance in stem cell biology (Dinger et al., 2008; Feng et al., 2006; Mattick and Makunin, 2005) .
Of note, several lncRNAs, including Hotair (Rinn et al., 2007) , LincRNA-RoR (Loewer et al., 2010) , Dali, MALAT1, Evf-2, and Nkx2.2AS (Chalei et al., 2014; Dinger et al., 2008; Guan et al., 2013; Ng et al., 2012; Ng and Stanton, 2013) , are implicated in stemness and cell fate determination, even though their functional characterization is still incomplete. In this scenario, there is a lack of studies that directly investigate the potential role of T-UCE family members in molecular mechanisms orchestrating the balance between proliferation and differentiation of mouse embryonic stem cells (ESCs) .
Here, we provide evidence of a functional role of T-UCEs in maintaining ESC self-renewal and get mechanistic insights into this process.
RESULTS

Genome-wide Profiling Reveals T-UCEs Differentially Expressed during ESC Neural Differentiation
To investigate the role of UCEs in ESC self-renewal/differentiation, we first searched for T-UCEs differentially expressed in undifferentiated versus differentiated ESCs. To this end, we performed a genome-wide expression profile analysis of T-UCEs in ESC neural differentiation by using a custom microarray designed to study the expression of both T-UCEs and miRNAs (Calin et al., 2007; Lujambio et al., 2010 ) and compared terminally differentiated cells (neurons and glia cells) with undifferentiated ESCs (Figure 1A) . Interestingly, out of the 962 T-UCEs, only 43 were differentially expressed (p < 0.001), the large majority of which (77%) were downregulated (Figures 1B and 1C; Table S1 ), whereas z150 miRNAs resulted differentially expressed (p < 0.001) ( Figure 1D ; Table S1 ). Of note, miR-9 was the most upregulated miRNA on the array (Figure 1D ), which was in line with the role of this miRNA (E) qRT-PCR analysis of miR-9-5p/3p, uc.170+, and Fam172a in ESCs and N/GCs. Relative RNA level was normalized to either Gapdh or U6 for coding/non-coding genes, respectively. Data are mean ± SEM (n = 3 independent experiments); **p < 0.005, ***p < 0.001. (F) ChIP-qPCR of H3K4me3 at uc.170+ (ultraconserved region) locus in ESCs and N/GCs. Data are mean ± SEM (n = 3 independent experiments); **p < 0.01. (G) Representative photomicrographs of the human ESC neural differentiation. Scale bar, 200 mm. (H) qRT-PCR analysis of uc.170+ in human ESCs and human neurons (RC17 and H9 are two different human ESC lines). Relative RNA level was normalized to U6. Data are mean ± SEM (n = 3 independent experiments); **p < 0.005, ***p < 0.001. See also Figure S1 .
family, both in the developing and adult vertebrate brain (Coolen et al., 2013) . The microarray results were validated by qRT-PCR of randomly selected uc.88+, uc.331+ A, uc.200+ A, uc.92+, and uc.452+ ) and miRNAs (miR-9-3p/5p, miR-714, miR-494, miR-181a, miR-411-5p, and miR-135b-5p) (Figures 1E, S1A , S1B, and S1C). Based on the T-UCE::miRNA functional interaction described in cancer cells (Calin et al., 2007; Olivieri et al., 2016) , we hypothesized that such interaction may also occur in ESCs. Therefore, we focused our attention on the most upregulated miRNA family, and identified putative miR-9 target sites in the differentially expressed T-UCEs by using miRBase software. Specifically, we focused on the 33 T-UCEs that showed a negative correlation with miR-9, i.e., they were downregulated in ESC differentiation, and selected the uc.170+, which showed the lower minimum free energy of binding to both the mature forms of miR-9 (DG: À27 kcal/mol and À14.8 kcal/mol for miR-9-5p and miR-9-3p, respectively) (Rehmsmeier et al., 2004 ) ( Figure S1D ).
In mouse, uc.170+ is localized on chromosome 13 within intron 6 of the Fam172a host gene on the opposite strand ( Figure S1E ); uc.170+ and Fam172a transcripts showed opposite expression profiles. Indeed, while uc.170+ expression was downregulated in ESC neuronal differentiation, Fam172a strongly increased ( Figure 1E ). We also examined the chromatin status at the uc.170+ locus by performing chromatin immunoprecipitation analysis (ChIP)-qPCR. Consistent with the expression profile of uc.170+, we found a specific enrichment of H3K4me3 in undifferentiated ESCs that was reduced in differentiated cells (Figure 1F) .
Bioinformatic analysis of the genomic region 5 0 upstream of the uc.170+ predicted a promoter region located at about 1.5 kb upstream of the uc.170+ that was not described so far, based on the presence of a TATA box, a transcriptional initiator (Inr), and/or a transcription start site (Figure S1E ). The predicted transcript containing the uc.170+ (T-UCstem1) was validated by northern blot analysis ( Figure S2A ). Furthermore, by using rapid amplification of cDNA ends-PCR analysis followed by sequencing, we identified the 5 0 and 3 0 extremities of the unspliced transcript and determined that its length is 1813 bp (Chr13: 78031716-78033528, strand -; Figure S2B ). Analysis of secondary structure prediction using two different algorithms showed that T-UCstem1 is able to form a complex secondary structure with several highly stable stem-loops, thus explaining the size of the transcript under native conditions ( Figures S2C and S2A ). Finally, we found that T-UCstem1 was expressed also in hESCs, and it was downregulated upon neuronal differentiation ( Figures 1G and 1H ), suggesting that it may similarly regulate human ESCs.
Direct and Functional Interaction of T-UCstem1 and miR-9
To assess whether there is a functional interaction between T-UCstem1 and miR-9, we performed a luciferase assay in 293FT cells. To this end, the uc.170+ was cloned in a luciferase reporter vector and co-transfected either with mimics of the mature forms of miR-9(3p/5p) or with a scrambled control (Figure 2A ). The luciferase activity was significantly reduced in the presence of miR-9(3p/5p), which was consistent with the computationally predicted T-UCstem1:: miR-9 interaction (Figure 2A ). Furthermore, site directed mutagenesis of the miR-9-3p and miR-9-5p seed sequences confirmed the specificity of the T-UCstem1::miR-9 interaction (Figure 2A ). To get further insights into the T-UCstem1::miR-9-3p/5p interaction, we extended the analysis to ESCs. First, we quantified the exact copy numbers of T-UCstem1 and miR-9 per cells in self-renewing ESCs by qRT-PCR. The mature miR-9 was present at a copy number of 9.6 ± 2.1 molecules/cell, which was significantly lower than T-UCstem1 (112 ± 13.8 copies/cell; Figure 2B ), thus supporting the idea that T-UCstem1 may be able to function as a sponge for miR-9 (Wang et al., 2013) . We therefore transfected ESCs with miR-9-3p/5p and assessed the expression of both T-UCstem1 and the miR-9 targets Lin28b, Tlx1, and Hes1 (Zhao et al., 2009 Coolen et al., 2013) (Figure 2C ). T-UCstem1 expression was strongly reduced already at 24 hr after transfection (Figure 2D) , thus providing further evidence of a functional interaction between T-UCstem1 and miR-9 also in ESCs. Interestingly, while the expression of pluripotency genes (Nanog, Sox2, and Oct4) was comparable ( Figure 2E ), proliferation was reduced in miR-9 compared with scrambletransfected ESCs (Figure 2F ). This observation prompted us to further investigate this phenotype. Consistently, cell-cycle distribution analysis of miR-9-transfected ESCs showed a significant G1-phase accumulation before S-phase progression compared with control, which was accompanied by a robust reduction in G2/M phase (Figure 2G) . This was also confirmed by 5-ethynyl-2 0 -deoxyuridine/propidium iodide (PI) double staining, which showed an enlargement of the S1 subphase in miR-9-transfected ESCs (21% miR-9-transfected ESCs versus 11% Control) ( Figure 2H ). To further analyze this phenotype and to evaluate the role of T-UCstem1 without altering the enhancer activity of genomic uc.170 (Pennacchio et al., 2006) , we generated stable T-UCstem1 knockdown (KD) ESC clones using custom-designed short hairpin RNAs (shRNAs) targeting non-overlapping regions of the transcript (SH1-3; Figure S1E) that markedly reduced (R70% of reduction) T-UCstem1 expression ( Figures 2I and S2A ). We first evaluated the effect of T-UCstem1 KD on the expression of the host gene Fam172a and two neighbor genes, Pou5f2 and Nr2f1. Fam172a was expressed at comparable levels in TUCstem1 KD (KD-1 and KD-2) and in Control ESCs, showing that T-UCstem1 does not regulate the host gene mRNA levels ( Figure 2J ). Of note, Nr2f1, but not Pou5f2, was significantly overexpressed in T-UCstem1 silenced ESCs ( Figure 2J ). Furthermore, we found a significant and consistent increase of both miR-9 mature forms upon T-UCstem1 KD ( Figure 2K ) and a consequential downregulation of the miR-9 targets Lin28b, Tlx1, and Hes1 ( Figure 2K ).
Altogether, these findings provide evidence of a functional interplay between T-UCstem1 and miR-9 in ESCs, and show that increased miR-9 cellular levels affect ESC proliferation.
T-UCstem1 Controls ESC Proliferation by Modulating miR-9 Intracellular Levels
To further investigate the functional role of T-UCstem1 in ESCs, we analyzed the molecular and cellular features of T-UCstem1 KD ESCs. Under FBS/Lif/Feeders culture conditions, T-UCstem1 KD ESC colonies appeared flat, disorganized, and smaller in size compared with Control, which conversely showed the expected domed and tightly packed (D and E) qRT-PCR analysis of (D) T-UCstem1, miR-9 targets (Lin28b, Tlx1, and Hes1), and (E) pluripotency-associated genes (Nanog, Sox2, and Oct4) in ESCs transfected with miR-9 or scr (100 nmol) for 24 and/or 48 hr. Data are mean ± SEM (n = 3 independent experiments); **p < 0.005, ***p < 0.001. (F) Automated cell counting of miR-9 and Control (scr) transfected ESCs at 24 and/or 48 hr. Data are mean ± SEM (n = 3 independent experiments); **p < 0.005. (G and H) FACS-based cell-cycle distribution analysis of ESCs transfected with miR-9 or miRNA scr for 48 hr (G) after PI or (H) after double 5-ethynyl-2 0 -deoxyuridine (EdU)/ propidium iodide (PI) staining (representative FACS plots of biological duplicates are shown). **p < 0.005. (I and J) qRT-PCR analysis of (I) T-UCstem1, (J) host and neighbor genes (Fam172a, Pou5f2, and Nr2f1) in NT and independent T-UCstem1 KD ESC clones. Relative RNA level was normalized to either Gapdh or U6 for coding/non-coding genes, respectively. Data are mean ± SEM (n = 3 independent experiments); **p < 0.005, ***p < 0.001. (K) qRT-PCR analysis of miR-9-3p/5p and its target genes, Lin28b, Tlx1, and Hes1. Relative RNA level was normalized to either Gapdh or U6 for coding/non-coding genes, respectively. Data are mean ± SEM (n = 3 independent experiments); **p < 0.005, ***p < 0.001. See also Figures S1 and S2. phenotype ( Figure 3A ). Expression levels of the pluripotency triad Oct4-Sox2-Nanog was comparable in KD and non-targeted (NT) ESCs ( Figures 3B and 3C) ; however, T-UCstem1 KD ESCs showed reduced proliferation rate (Figure 3D ), which was accompanied by reduced cell viability ( Figure S3A ) and induced apoptosis, as shown by CASPASE9 activation and PARP cleavage ( Figure 3E ). Furthermore, PI staining showed accumulation of T-UCstem1 KD ESCs in G1 phase, which eventually resulted in S-phase pauperization ( Figure 3F) . Accordingly, the expression of cellcycle inhibitors p27 and p21 was strongly upregulated in T-UCstem1 KD cells compared with NT Control ( Figure 3G ). This mutant phenotype was further supported by carboxyfluorescein succinimidyl ester (CFSE) staining, which tracks cell division in living cells over the time (Ramírez et al., 2011) (Figures S3B-S3D ). Interestingly, small interfering RNA-based knockdown of T-UCstem1 in hESCs ( Figure S3F ) resulted in decreased colony size and reduced cell proliferation rate (Figures S3G and S3H) , suggesting a conserved role of T-UCstem1 in hESCs.
We then asked if uc.170+ overexpression was able to rescue the molecular and functional phenotype of T-UCstem1 KD ESCs. Interestingly, uc.170+ overexpression fully rescued mir-9 levels and expression of the target genes (Lin28b and Tlx1; Figures S3I and S3J ), as well as T-UCstem1 KD colony size and proliferation rate ( Figures S3K and S3L ). Of note, mir-9 overexpression ( Figures 2D-2I ) and T-UCstem1 depletion ( Figures 3D, 3F , and 3G) similarly affected ESC proliferation, thus suggesting that T-UCstem1 KD phenotype could be due to increased mir-9 levels. To test this hypothesis, T-UCstem1 KD ESCs were transfected with antagomiR-9 or scrambled control ( Figure 3H ). AntagomiR-9 reduced miR-9 levels and restored Lin28b and Tlx1 expression in T-UCstem1 KD ESC (Figures S4A and S4B) , and rescued proliferation ( Figures 3I and S4C) . Furthermore, overexpression of the miR-9 target gene Lin28b ( Figures S4D and S4E ) was also able to fully rescue T-UCstem1 KD ESC proliferation ( Figures 3H and 3J ).
All together, these data demonstrate that a T-UCstem1/ miR-9/Lin28b axis controls cell-cycle progression in ESCs.
T-UCstem1 Preserves ESC Self-Renewal Properties
In Vitro and In Vivo Despite their morphology and altered proliferation rate, FBS/Lif/Feeders T-UCstem1 KD ESCs retained a proper expression of pluripotency markers ( Figures 3B and 3C ). Nevertheless, when T-UCstem1 KD ESCs were plated at low density in colony-formation assay, and in the absence of feeders (Paling et al., 2004) , colonies with a flat morphology massively increased at the expense of the classical domed colonies (Figure 4A) , and this effect was exacerbated already after one passage in culture (Figures S4F and S4G) . In line with these observations, expression of pluripotency factors was strongly reduced in T-UCstem1 KD ESC colonies in these culture conditions (FBS/Lif, low density) (Figures 4B, 4C, and S4H-S4J). Interestingly, this correlated with a significant increase in the expression of cell lineage commitment genes (i.e., Fgf5, Brachyury, Sox17, Foxa2, Sox1, and Nestin) at both RNA ( Figure 4C ) and protein ( Figure 4D ) levels.
We then asked whether this phenotype could be rescued in 2i (CHIR99021 + PD0325901) culture conditions ). Intriguingly, while T-UCstem1 KD ESC selfrenewal was fully rescued in 2i, as indicated by alkaline phosphatase staining ( Figure 4E ) and expression of pluripotency-associated genes ( Figures S4K and 4F ), the reduced proliferation rate ( Figure S4L ), as well as the expression of cell-cycle inhibitor p21 persisted ( Figure 4F ), thus suggesting that different mechanisms control T-UCstem1-dependent regulation of ESC proliferation and self-renewal.
In line with our in vitro findings that T-UCstem1 silencing affected ESC proliferation and self-renewal, but not pluripotency, T-UCstem1 KD ESCs generated teratomas significantly smaller in size compared with Control, but not different in histological composition (Figures 4H and 4I) . Furthermore, EGFP-labeled T-UCstem1 KD ESCs efficiently contributed to chimeric embryos upon injection into morula (Figures 4G and S5A ; eight out of nine embryos analyzed).
Altogether, these findings provide evidence of a crucial role of T-UCstem1 in preserving ESC self-renewal and proliferation both in vitro and in vivo, without affecting pluripotency.
T-UCstem1 Silencing Accelerates and Enhances ESC Differentiation
To further assess the functional role of T-UCstem1 in ESCs, we evaluated the impact of T-UCstem1 KD on ESC differentiation. A time course analysis of ESC neural differentiation showed a significant difference in the differentiation kinetics of T-UCstem1 KD and Control ESCs. Specifically, neural and glial differentiation strongly increased in T-UCstem1 KD ESCs compared with Control ( Figure 5A ). Indeed, markers of neural precursors (Sox1 and Nestin), fully differentiated neurons (bIII-tubulin), and glial cells (glial fibrillary acidic protein) were all upregulated in T-UCstem1 KD ESCs already at earlier time points of differentiation (Figures 5B and 5C), suggesting that differentiation was accelerated in T-UCstem1 KD cells. Consistently, while Oct4 was downregulated in T-UCstem1 KD culture, its expression persisted in Control ESCs ( Figure 5C ). Finally, fluorescence-activated cell sorting (FACS) analysis showed increased neural and glial cells in T-UCstem1 KD culture, thus further supporting the idea that ESC differentiation was accelerated and was more efficient upon T-UCstem1 downregulation ( Figure 5D ). To further evaluate this phenotype, we evaluated the effect of T-UCstem1 KD on ESC cardiac differentiation. Time course expression analysis showed a transient upregulation (day 6) of the pan-mesodermal marker Brachyury in T-UCstem1 KD cultures, which progressively decreased (Figure S5B) , and increased expression of both early (Nkx2.5) and late (a-myosin heavy chain [aMHC]) cardiac markers throughout differentiation (days 6-10; Figure S5B ), suggesting that cardiac specification and differentiation was enhanced and accelerated. Accordingly, FACS analysis showed that Brachyurypositive cells were strongly reduced (10.8% ± 2.2% KD versus 21.1% ± 3.7% Control) at day 8, while aMHC (MF20)-positive cells almost doubled at day 10 (27% ± 3.7% KD versus 12.3% ± 3.1% Control) in T-UCstem1 KD cell culture compared with Control ( Figure S5C ), which is in line with accelerated differentiation.
All together, these results indicate that T-UCstem1 is required to regulate ESC differentiation.
T-UCstem1 Preserves the Transcriptional Dynamics of ESCs by Stabilizing PRC2 Complex
To get mechanistic insight into the role of T-UCstem1 in ESC self-renewal and differentiation, we compared RNA sequencing (RNA-seq) transcriptome profiling of FBS/Lif/ Feeders T-UCstem1 KD and Control ESCs, and identified more than 1,000 deregulated genes (fold change R2; p < 0.05; Figure 6A ; Table S2 ). Remarkably, gene ontology (GO) analysis showed striking enrichment in genes involved in regulation of cell proliferation, positive regulation of development, and positive regulation of cell differentiation (Figure 6B) , which are in line with the functional role of T-UCstem1 (Figures 3, 4 , and 5). The large majority of the deregulated genes were indeed upregulated ($70%) in T-UCstem1 KD ESCs compared with Control and, remarkably, $50% were associated with bivalent chromatin domains ( Figures 6C and 6D ). Bivalent domains are characterized by the co-presence of the activating H3K4me3 and the repressive H3K27me3 histone marks, and are associated with silencing of developmental genes that would activate cell differentiation, while keeping these genes poised and ready to be induced (Bernstein et al., 2006) . We thus first analyzed the status of H3K4me3 and H3K27me3 at the bivalent domains of Nestin, Foxa2, and Gata6 genes in T-UCstem1 KD and Control ESCs by ChIP . T-UCstem1 Sustains ESC SelfRenewal In Vitro and In Vivo (A) Representative pictures of crystal violet-stained and colony-type frequency ($100 colonies scored/condition) of colonies generated from Control (NT) and T-UCstem1 KD ESCs, at day 6 after plating. Data are mean ± SEM (n = 3 independent experiments); **p < 0.005. Scale bar, 100 mm. (B) Representative immunofluorescence of NANOG/OCT4 and SOX2/OCT4 of Control (NT) and KD ESC colonies at day 6 after plating. Nuclei were stained with DAPI. Scale bars, 75 mm. (C) qRT-PCR analysis of pluripotency (Nanog, Sox2, and Oct4), mesodermal (Fgf5 and Brachyury [Bra]), neural (Sox1 and Nestin), and endodermal-associated genes (Foxa2 and Sox17) in Control (NT) and two independent T-UCstem1 KD ESC clones. Relative RNA level was normalized to Gapdh expression. Data are mean ± SEM (n = 3 independent experiments); *p < 0.01, **p < 0.005, ***p < 0.001. (D) Representative pictures of NESTIN, BRA, and SOX17 immunostaining in KD ESC colonies. Nuclei were stained with DAPI. Scale bars, 75 mm. (E) Representative pictures of alkaline phosphatase (AP)-stained colonies generated from Control (NT), KD, and KD + 2i (CHIR99021 + PD0325901) ESCs, at day 6 after plating. Scale bar, 100 mm. (F) Western blot analysis of PARP full-length form and cleaved fragment, p21, NANOG, and SOX2 in Control (NT), KD, and KD + 2i (CHIR99021 + PD0325901) ESCs, at day 6 after plating. GAPDH was used as a loading control. (G) Representative photomicrograph by Axio Zoom.V16 Zeiss microscopy (original magnification 310) of chimeric embryos from EGFPlabelled T-UCstem1 KD ESCs injected into morula and dissected at embryonic day 9.5 (E9.5). analysis. In line with the expression data ( Figures 6A and  S6A) , the H3K4me3/H3K27me3 ratio (De Gobbi et al., 2011) significantly increased in T-UCstem1 KD ESCs at the promoter of these representative genes of the three germ layers ( Figure S6C ). Of note, we found derepression of Nestin, Foxa2, and Gata6 genes also in T-UCstem1 KD hESCs (Figure S6B) , suggesting that T-UCstem1 function may be conserved in humans. Given the very well-documented role of polycomb repressive complex 2 (PRC2) in maintaining the bivalent domains in ESCs and the involvement of several lncRNAs in this mechanism (Margueron and Reinberg, 2011) , we questioned whether T-UCstem1 could directly interact with the PRC2, and eventually regulate bivalent gene expression. To address this issue, we first analyzed the subcellular localization of T-UCstem1 by RNA subcellular fractionation. According to its interaction with miR-9 in ESCs, T-UCstem1 was detected in the cytoplasmic fraction ( Figure 6E ). However, T-UCstem1 was also present both in the nuclear soluble and in the chromatin-associated fractions (Figure 6E ), supporting the idea of a potential role of this lncRNA also in the nucleus. We then assessed whether T-UCstem1 might physically interact with components of PRC2, and carried out a crosslinked RNA immunoprecipitation using SUZ12 and EZH2 specific antibodies. We found that T-UCstem1 was able to specifically bind both SUZ12 and EZH2 proteins of PRC2 ( Figure 6F ). Native RIP carried out on cell lysate revealed that SUZ12 shows presumably higher affinity in this interaction than EZH2 ( Figure S6D ). These findings led us to hypothesize a role of T-UCstem1 in stabilizing the PRC2 complex on its target genes. To address this question, we analyzed SUZ12 and EZH2 binding on Nestin, Foxa2, and Gata6 promoters by ChIP experiments and found that T-UCstem1 downregulation significantly reduced PRC2 occupancy on all the target sites analyzed (Figures 6G and S6E ). Of note, SUZ12 and EZH2 protein levels were comparable in T-UCstem1 KD and Control ESCs (Figure S6F ). To prove that T-UCstem1 interacts with Nestin, Gata6, and Foxa2 genes showing changes in H3K4me3/H3K27me3 ratio, we performed chromatin isolation by RNA purification (ChIRP). We found a significant enrichment of T-UCstem1 at the target sites of PRC2 occupancy, while this enrichment was not detected at Sox2 promoter ( Figure 6H ).
Overall, these data point to a key role of T-UCstem1 in maintaining ESC transcriptional identity by protecting the epigenetic status of key developmental regulatory genes, stabilizing PRC2 on their bivalent domains.
DISCUSSION
This work provides evidence of a functional role of T-UCEs in regulating the finely tuned balance between pluripotency (E) Total RNA from ESCs was separated into cytoplasmic, nuclear-soluble, and chromatin-bound fractions. The relative abundance of T-UCstem1 in the different fractions was measured by qRT-PCR. Gapdh and Xist were analyzed as control. Data are mean ± SEM (n = 3 independent experiments). (F) Crosslinked RNA immunoprecipitation (c-RIP) of T-UCstem1 in ESCs, using antibodies against SUZ12, EZH2, or immunoglobulin (IgG) as control. U6 was analyzed as negative control. Data are mean ± SEM (n = 3 independent experiments); *p < 0.05, **p < 0.005. (G) ChIP-qPCR of SUZ12 and EZH2 binding at selected genes in NT and KD cells. Myo6 promoter has been reported as control. Data are mean ± SEM (n = 3 independent experiments); *p < 0.05, **p < 0.005, ***p < 0.0005. (H) ChIRP-qPCR for T-UCstem1 in ESCs. Enrichments of Nestin, Gata6, Foxa2, and Sox2 promoter regions were quantified in the chromatin fraction precipitated using biotinylated DNA probes complementary to T-UCstem1 and LacZ as negative control. Sox2 promoter has been reported as negative control. Data are mean ± SEM (n = 3 independent experiments); *p < 0.05, **p < 0.005. See also Figure S6 . and differentiation in mouse ESCs. So far, the T-UCEs have been mostly linked to cancer, whereas their physiological role is still poorly understood. Based on the hypothesis that the T-UCE::miR interaction described in cancer cells can similarly occur in ESCs, we focused on uc.170+::mir9 since (1) uc.170+ carries the seed sequence for miR-9, and (2) uc.170+ and mir-9 expression inversely correlate in ESC neural differentiation. Here, we demonstrate that T-UCstem1 and miR-9 functionally interact and show that T-UCstem1::miR-9 interplay regulates ESC proliferation. According to our findings, recent data showed that miR-9 inhibits neural precursor cell and ESC proliferation by targeting Tlx1 (Qu et al., 2010; Zhao et al., 2009) Xu et al., 2009; Zhong et al., 2010) , respectively. Our results that Lin28b overexpression rescues the proliferation defects of T-UCstem1 KD ESCs support the conclusion that a T-UCstem1/miR-9/Tlx1-Lin28b axis controls cell-cycle progression in ESCs.
Besides its pro-proliferative activity, T-UCstem1 also acts as a brake for ESC differentiation. Indeed, genome-wide and targeted analysis indicate that, upon T-UCstem1 silencing, FBS/Lif/Feeders ESCs retain expression of key pluripotency factors but concomitantly induce the expression of a large set of developmental genes of the three germ layers (ectoderm, mesoderm, and endoderm). In line with this peculiar molecular signature, FBS/Lif/Feeders T-UCstem1 KD ESCs keep pluripotency features and are able to differentiate in vitro and contribute to chimeric embryos in vivo. On the other hand, in less-permissive culture conditions (low density without feeders) FBS/Lif T-UCstem1 KD ESCs rapidly exit pluripotency and undergo differentiation, pointing to a key role of T-UCstem1 in preserving ESC self-renewal rather than pluripotency. Of note, since T-UCstem1 expression is not fully abrogated in T-UCstem1 KD ESCs, we cannot rule out the possibility that a complete loss of T-UCstem1 expression could give a more dramatic effect.
The observation that T-UCstem1 KD ESC self-renewal, but not the proliferation defects, were rescued in 2i culture conditions, suggests different mechanisms of action of T-UCstem1-dependent control of ESC proliferation and self-renewal. Indeed, a large number ($50%) of all the developmental regulatory genes that are upregulated in T-UCstem1 KD ESCs are bivalent domains-associated genes, which are characterized by a distinctive histone modification signature that combines the activating H3K4me3 and the repressive H3K27me3 marks. These bivalent domains are considered to poise expression of developmental genes, allowing timely activation, while maintaining repression in the absence of differentiation signals (Voigt et al., 2013) . Increasing evidence indicates that PRC2 plays a crucial role in maintaining the bivalent domains in ESCs (Aranda et al., 2015) by ensuring a proper and robust differentiation.
Withdrawal of PRC2 activity from ESCs results in global gene derepression of bivalent-associated genes (Azuara et al., 2006; Boyer et al., 2006; Lee et al., 2006) and spontaneous differentiation Endoh et al., 2008) . PRC2 interacts with many lncRNAs in ESCs (e.g., HOTAIR, Malat1, and Gtl2), and these facilitate its recruitment to chromatin . Furthermore, recent findings indicate that non-coding RNAs recruit PRC2 complex to chromatin either in cis or in trans, thereby causing changes in chromatin composition (Holoch and Moazed, 2015) . Our findings indicate that T-UCstem1 is a new player in this complex scenario and provide evidence of a direct involvement of T-UCstem1 in switching the balance of these histone modifications in ESCs. Indeed, we show that T-UCstem1 directly interacts both with PRC2 complex and the bivalent domain-associated genes Nestin, Gata6, and Foxa2, and that this interaction may stabilize/guide PRC2 activity in determining the typical histone modifications at these bivalent domains. Thus, we propose a model wherein PRC2 is displaced in the absence of T-UCstem1, and this results in increased H3K4me3/H3K27me3 ratio on bivalent promoters of differentiation genes, which eventually induces their expression. Notably, we demonstrate that, besides the regulation on bivalent genes localized on different chromosomes (i.e., Nestin, Gata6, and Foxa2), T-UCstem1 also controls the expression of the neighbor bivalent gene Nr2f1 (Laursen et al., 2013) , thus suggesting that the T-UCstem1 tethers PRC2 both in cis and in trans. Of note, considering the low abundance of T-UCstem1 and the $400 bivalent genes that are deregulated in the T-UCstem1 KD ESCs, we speculate that they might represent both direct and indirect targets of T-UCstem1.
In summary, we provide unprecedented evidence that a UCE-containing lncRNA is a key regulator of ESCs and get mechanistic insights into the mode of action. Indeed, we propose that T-UCstem1 exerts a dual function in ESCs; specifically, it controls ESC proliferation by regulating miR-9/Lin28b cellular levels in the cytoplasm, and maintains ESC transcriptional dynamics and self-renewal, at least in part through PRC2 stabilization in the nucleus. Overall, our study points to a functional role of T-UCEs in ESC biology, and pave the way for a better understanding of the complex molecular machinery controlling ESC pluripotency and lineage specification.
EXPERIMENTAL PROCEDURES
T-UCstem1 KD Mouse ESC Generation
Animal experiments were done in accordance with the law on animal experimentation (article 7; D.L. 116/92) under the Animal Protocol approved by the Italian Ministry of Health.
Stable T-UCstem1 KD ESC clones (designated as KD-1 and KD-2) were generated by using custom-designed shRNAs targeting Stem Cell Reports j Vol. 10 j 1102-1114 j March 13, 2018 1111 non-overlapping regions of the transcript (different shRNAs were used in order to limit the off-target effects). For this purpose, we used the BLOCK-iT Inducible H1 RNAi Entry Vector Kit (Invitrogen, cat. no. K4920-00 and K4925-00), a Gateway-adapted entry vector for regulated expression of shRNA in mammalian cells, following the manufacturer's instructions. In brief, we designed custom shRNA taking advantage of Invitrogen's RNAi designer and we cloned them into pENTR/H1/TO vector. Next, plasmid constructs that direct shRNA expression were introduced into ESCs (TBV2 (129/SvP)) by electroporation and drug selection (Zeocin). Then, we isolated ESC constitutively expressing shRNAs clones, we propagated them, and the degree of knockdown was assessed by qRT-PCR. Selected ESC clones were used for this study.
In particular, to silence T-UCstem1, we used three different shRNAs reported in Supplemental Information. Moreover, we generated NT ESCs, to use as Control, by transfecting the cells with shRNA targeting LacZ gene and supplied in the kit.
Whole-Genome Expression Analysis
RNA was extracted from NT and KD ESCs using TRIzol reagent (Thermo Fisher Scientific). To identify the expression profile of T-UCEs and miRNAs, the total RNA was hybridized to a custom ncRNA microarray (OSU-CCC 4.0, Ohio State University Comprehensive Cancer Center), which included sense and antisense probes, one corresponding to the sense genomic sequence (+) and the other to the complementary sequence (+A) for all 481 human ultraconserved sequences reported by Bejerano et al. (in total there are probes for 962 possible T-UCEs). The GEO describes the OSU-CCC 4.0 platform under accession number GPL14184. T-UCEs were retained when present in at least 20% of samples and when at least 20% of them had a fold change of more than 1.0 from the gene median. Absent calls were thresholded prior to normalization and statistical analysis. Normalization was performed using quantiles (Table S1) .
RNA-seq was performed at the Institute for Applied Genomics using the Illumina HiSeq 2500 platform (http://www.igatechnology. com/). The data were analyzed by aligning the reads to a reference genome (Mus musculus mm9) using Tophat (Trapnell et al., 2009) , which is also able to align sequences that span exon-exon junctions. Then, we performed a differential expression analysis using Cufflinks (Trapnell et al., 2010) , which is able to calculate transcript abundance and abundance of different gene isoforms. Finally, this analysis showed the most deregulated transcripts when comparing them with the different groups (Table S2) . Actually, in order to avoid clonal effects, we analyzed three independent KD ESC clones generated as described above and the average values were reported. A custom R-script was used to create the plot in Figure 6A .
T-UCstem1 ChIRP
ChIRP assay was performed using the Magna ChIRPTM RNA Interactome Kits (Millipore) according to the manufacturer's instructions. Biotin-labeled antisense T-UCstem1 DNA probe sequences are reported in Supplemental Information. Isolated DNA was used for qPCR analyses to estimate the site occupancy of T-UCstem1 on the Nestin, Gata6, and Foxa2 promoter. The site occupancy was calculated as ratio between the percent input of each specific target qPCR and the average of the percent input of the internal negative control (Sox2). Data are shown as the site occupancy mean.
ACCESSION NUMBERS
The accession numbers for the ncRNA (T-UCE and miRNAs) expression profile and RNA-seq data are ArrayExpress: E-MTAB-6391 and GEO: GSE108662, respectively. Table S3 . Primers sets used in this study. 
SUPPLEMENTAL INFORMATION
GENE NAME FORWARD PRIMER REVERSE PRIMER T-UCstem1 TGAGTCTTTGCCTCTCTTTGG AAGTGCTGAAGCACCCCTTA
Gapdh
TGGGGGAACTTAAAGTGCAG GATGTAGGCAGCTGTCATTC
Fam172a
TGAAAAAGGACGAACCACCT TCGCCCAGAGCTTCATATCT
Nanog
AAGTACCTCAGCCTCCAGCA GTGCTGAGCCCTTCTGAATC
Nr2f1
ATCCGCATCTTTCAGGAACA TGATTTCTCCTGCAGGCTTT
Oct3/4 TCAGCTTGGGCTAGAGAAGG TGACGGGAACAGAGGGAAAG
Sox1
GCAGCTATCAACCAGATCC GATGTAGGCAGCTGTCATTC
Brachyury
GAACCTCGGATTCACATCGT TTCTTTGGCATCAAGGAAGG
Hes1
TGAAGGATTCCAAAAATAAAA TTCTCTGGG CGCCTCTTCTCCATGATAGGC TTTGATGAC
Tlx1
GGTCACCCCTATCAGAACCG TTTTACTTGCGCATCGGTCA
Sox17
AGCTAAGCAAGATGCTAGGC AAG TCTCTGCCAAGGTCAACGC
Foxa2
ACCTGAGTCCGAGTCTGAGC TGTAGCTGCGTCGGTATGTC
Gata6
GCCAACTGTCACACCACAAC GGTTTTCGTTTCCTGGTTTG
Gata6 promoter
ACTTTTTCTGGAGCTCGCGT GTTCCGCACGTGGAAATAGC
Nestin promoter
GGTGCGTGACTACCAGGAG TGCACCTCTAAGCGACTCTC
Foxa2 promoter
CCTGGAGAGACCCGTTTAGC CCACCTACTGCCCTGTTTGT
Myo6 promoter
GCTCCGTAGCAGTGACGTG GAGCACCGGAGACGACAG
Nr2f1 promoter
TGGGAGAGTCGAGCAGGATC AGCGCTGCCTTCCTGAATG
T-UCstem1 genomic locus
ACCCAGTGACATCATGTTTTG CTTCCCACAATGACCTATGTCA
T-UCstem1 (RIP)
AATCGTCCACAGCAGACCTC AGGAGAGCTGGGAGAGTGTG 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES ESC culture and differentiation
NT and T-UCstem1 KD ESCs were cultured in serum/LIF/Feeders, as previously described (Bedzhov et al., 2014) . 2i/LIF comprises the Mek inhibitor PD0325901
(Selleckchem.com, 1 µM), the Gsk3 inhibitor CHIR99021 (Selleckchem.com, 3 µM), and leukemia inhibitory factor (Lif, Millipore100 U/ml) in F12/Neurobasal medium ). The serum-free mono-step neural differentiation protocol was previously described . Briefly, cells were seeded at 1. 
T-UCstem1 shRNA sequences
In particular, to silence T-UCstem1, we used three different shRNA reported below:
Among the KD ESC clones obtained, we used KD-1 and KD-2 clones, derived by using Sh1 and Sh2 respectively.
In silico prediction alignment in ultraconserved RNA sequences base pairing with miRNAs
The target prediction tools miRBase (Kozomara and Griffiths-Jones, 2014) and RNAhybrid (version 2.1, Bielefeld University) were used to identify putative miRNA target sites in T-UCE sequences described by Bejerano et al. T-UCE::miRNA duplex formation was evaluated under highly stringent conditions using pvalue< 0.05 and ΔG< -12 Kcal/mol.
In silico prediction of T-UCstem1 promoter and secondary structure
We used two independent promoter prediction tools: 1) ElemeNT (Sloutskin et al., 2015) , reporting a TATA box at 1595bp (TATAAAAA PWM score 1.00) and an Inr (1,554bp upstream uc.170+). Default parameters were used for the above mentioned prediction tools.
For the T-UCstem1 secondary structure prediction Minimun Energy Free (MEF) and
Centroid algorithms (available in the RNAfold suite) were used with the default parameters (Gruber et al., 2008) .
Colony Formation Assay
Colony-formation assay was performed as previously described (Chambers et al., 2007) . Briefly, ESCs were trypsinized to obtain a single cell suspension and plated at low density (100 cells/cm 2 ). After 6 days, colonies were fixed in 4% paraformaldehyde (PFA) and stained with crystal violet and alkaline phosphatase as previously described (D'Aniello et al., 2015) . Images were collected on a DMI6000B microscope (Leica Microsystems). The morphological classification (domed/flat) was performed blinded by two investigators.
hESC Culture and Differentiation
The human Embryonic Stem Cell (hESC) line H9 (WiCell, cat. no. hPSCreg WAe009-A) and RC17 (Roslin Cells, cat. no. hPSCreg RCe021-A) were used in this study and were kindly provided by Prof. Malin Parmar (Wallenberg Neuroscience
Center, Lund University, Sweden). Undifferentiated hESCs were maintained in culture on Lam-521 (100 µg/ml; Biolamina, cat. no. LN-521) in iPS-Brew XF (StemMACS; Miltenyi, and passaged with EDTA (0.5 M, pH 8.0; Thermo Fisher Scientific, cat.no 15575020) ( ). H9 and RC17 cell lines were differentiated toward human ventral midbrain dopaminergic neurons progenitors according to Nolbrant et al ((Nolbrant et al., 2017) . Briefly, the hESCs were seeded to a concentration 10,000 cells per cm 2 , in DMEM/F12:Neurobasal (1:1), N2 supplement (1:100; Thermo Fisher Scientific, cat.
no. A1370701) onto plastic-ware coated with Lam111 (100 ug/ml; Biolamina, cat. no.
LN-111). Patterning factors SB431542 (10 uM; Miltenyi, cat. no. 130-106-543), Noggin (100 ng/ml; Miltenyi, cat. no. 130-103-456), Shh-C24II (300 ng/ml; Miltenyi, cat. no. 130-095-727) and CHIR99021 (Miltenyi, were also present in the medium from day 0 to day 8. From day 9 of differentiation, FGF8b
(100ng/ml; Miltenyi, cat. no. 130-095-740) was added to the medium and on day 11, cells were re-plated at 800.000 cells per cm 2 in DMEM/Neurobasal, B27 supplement
(1:100; Thermo Fisher Scientific, cat. no. 12587010). Patterning factors BDNF (20ng/ml, Miltenyi, cat. no. 130-096-286), AA (0,2mM, Sigma-Aldrich, cat. no. A4403-100MG) FGF8 (100ng/ml) were added. For terminal differentiation, the cells were replated at day 16 to a concentration 155,000 cells per cm 2 in DMEM/Neurobasal with B27 supplement with BDNF (20ng/ml), AA (0,2mM) GDNF (10ng/ml, R&D Systems, cat. no. 212-GD-010) db-cAMP (500uM Sigma-Aldrich, cat. no. D0627-1G) and DAPT (1uM, 
Cloning and Site-Directed Mutagenesis
After WT cloning, QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) was used to generate the deletion of 4bp from the site of complementarity between uc.170+ and both miR9-5p and miR9-3p, by PCR using the WT WT and mutant inserts were confirmed by sequencing.
Rapid Amplification of cDNA Ends (RACE)-PCR
To identify the 5′ and 3′ ends of the uc.170+ transcript, total RNA from ESCs was extracted and treated with DNase I (RNase-free) endonuclease, and the SMARTer RACE 5'/3' kit (Clontech) was used to generate RACE-ready cDNA according to the manufacturer's instructions. The cDNA ends were amplified with SeqAmp DNA Polymerase (Takara), and gene-specific primers (GSP1: 5′-AGGGGTGATATGCATGTGCT-3′; GSP2: 5′-TGAGAAGGGGACGAGGGTTGCTACA -3′) were used. Furthermore, nested PCR analysis was performed with the nested universal primer provided with the kit (SMARTer RACE cDNA Amplification kit) and two nested gene-specific primers (NESTED-GSP1: 5′-TGCTGAAGCACCCCTTAAGCCCACT-3′; NESTED-GSP2: 5′-GGGCATACAGCCCCCTCCCCGTACTC-3′). Mouse heart RNA and transferrin receptor-specific primers provided with the kit were used as reaction controls. The PCR fragments were then run on a 1.5% agarose gel, and DNA was extracted from the gel using a QIAquick Gel Extraction kit (QIAGEN) according to the manufacturer's instructions. The RACE products were then cloned into a TOPO TA pCR2.1 cloning vector (Thermo Fisher Scientific) according to the manufacturer's instructions. The sequences were obtained by using the T7 and GSPs primers and verified by using the UCSC Genome Browser (University of California Santa Cruz).
Flow cytometry
Single cell suspensions of ESC-derived neurons, were obtained using either trypsin-EDTA or TrypleSelect 1x (Gibco), fixed, stained with the appropriated primary and secondary antibodies according to the manufacturer's protocols, and were analysed with a BD FACS CantoIITM cytofluorimeter (BD Biosciences). Details and list of antibodies are in Table S4 .
Cell Cycle and Proliferation assays
For Cell Cycle analysis, the cells were dissociated to single cell suspension, fixed with cold 70% ethanol before propidium iodide (PI) staining (20 µg/ml) and were analysed by flow cytometry using a BD FACS CantoIITM cytofluorimeter (BD Biosciences). Cell viability was measured using the colorimetric CyQuant determined by using a size marker run on the same gel. Total RNA (1µg) was reverse-transcribed using, QuantiTect Reverse Transcription kit (Qiagen). RT-qPCR was performed using strand-specific primers for T-UCE analysis and random primers for coding-gene expression. A miRCURY LNA Universal RT miR PCR kit (Exiqon)
was used for miRNA analysis according to the manufacturer's instructions. Small nuclear RNA U6 was used as a reference for T-UCEs and miRNAs. The sequences of primers are reported in Table S3 .
The relative amount of specific transcripts was measured by RT-PCR analysis.
Briefly, it was performed using an iQ SYBR Green Supermix (BioRad) protocol with a CFX96Deep Well system RealTime PCR Detection System (Bio-Rad), according to the manufacturer's instructions. The copy number of transcripts per cell was calculated by the comparative cycle threshold method presented by Livak and Schmittgen (Livak and Schmittgen, 2001 ).
RNA fractionation
The RNA fractionation was performed as described by Cabianca DS et al. (Cabianca et al., 2012) . Briefly, ESC were detached by treating with 1X Trypsin, counted and Total RNA was extracted by using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions; in particular, the extraction from aqueous solutions was followed for the cytoplasmic and nuclear-soluble fractions, whereas the chromatin-associated fraction was considered as a pellet. Gapdh and Xist were used as quality control of the RNA fractionation.
Western Blotting
Whole cell lysates were prepared with ice-cold immunoprecipitation assay (RIPA) lysis buffer. Detection was performed with ECL reagents (Amersham Biosciences).
Details and list of antibodies are in Table S4 . 
Luciferase
EGFP-labelled ESCs and Chimera generation
GFP was inserted in both NT and T-UCstem1 KD ESCs at the Rosa26 locus by using the R26P-SA-EGFPpuro plasmid (Addgene). Ten days after transfection, puromycin-selected clones were verified for correct self-renewal and differentiation properties. Chimeras were obtained by injecting NT and T-UCstem1 KD GFP- 
Teratoma Assay
ESCs were trypsinized into single-cell suspension and resuspended in phosphatase buffered saline (PBS). ESCs (3x10 6 ) were injected subcutaneously into hind limbs of severe combined immunodeficiency mice (SCID). Teratomas were collected, fixed in 4% PFA, sectioned and stained with hematoxylin/eosin or subjected to immunohistochemistry for the histological analysis.
Immunohistochemistry
Samples were processed with the standard streptavidin-biotin-immunoperoxidase method (DAKO Universal Kit, DAKO Corp., Carpinteria, CA, USA). Diaminobenzidine was used as the final chromogen, and hematoxylin as the nuclear counter stain.
Immunofluorescence
Cells were fixed (4% PFA) and permeabilized (0.1% Triton X-100), where necessary, at room temperature. After incubation with primary antibodies, cells were incubated (1h) with the appropriate secondary antibodies (Alexa Fluor 488 and/or 594 (1:200); Molecular Probes). Details and list of antibodies are in Table S4 .
Chromatin Immunoprecipitation (ChIP)
Chromatin immunoprecipitation to detect H3K4me3, H3K27me3, Suz12 and Ezh2 enrichments was performed according to a previously validated protocol (Comes et al., 2013) . Briefly, 1x10 6 cells for NT and KD ESCs were fixed with formaldehyde at room temperature (RT, 10 min), followed by glycine (125 mM) to stop the crossing linking reaction (RT, 5 min). Nuclear extracts were sonicated using a Covaris S2 system sonicator according to manufacturer's instructions to achieve chromosome fragment lengths of 200-500 bp. After sonication, suitable amount of chromatin was incubated with the specific antibodies (Table S4 ). Immunoprecipitated complexes were recovered with protein A sepharose and samples were then washed with low and high salt buffers, reverse-crosslinked, and purified using the QIAquick PCR purification kit (Qiagen). Purified DNA was analysed by RT-qPCR using genespecific primers (Table S3) .
RNA Immunoprecipitation (RIP)
Native RNA immunoprecipitation experiments were performed using the Magna RIP™ RNA-Binding Protein Immunoprecipitation Kit (Millipore) according to the manufacturer's instructions. Briefly, 20x10 6 NT ESCs were lysed to isolate nuclei in presence of protease and RNAse inhibitors, which were then treated with DNAseI.
The complex magnetic beads-antibody was prepared and the immunoprecipitation followed for 4-16 hours or overnight. The antibodies anti-Suz12, anti-Ezh2 and antiIgG used are reported in Table 4 . RNAs from the immunoprecipitated and input fractions were purified, retrotranscribed using T-UCstem1-specific oligonucleotide and cDNAs were used for RT-qPCR.
Probes used for T-UCstem1 ChIRP
Biotin-labeled antisense T-UCstem1 DNA probes were designed using the suggested web tool (www.singlemoleculefish.com). We compared the probe 
